Elevated GM-CSF and IL-1beta levels compromise the ability of p38 MAPK inhibitors to modulate TNFalpha levels in the human monocytic/macrophage U937 cell line.

Source:http://linkedlifedata.com/resource/pubmed/id/20617251

Download in:

View as

General Info

PMID
20617251